IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $154 | -100.0% | 21,851 | -48.6% | 0.01% | -87.4% |
| Q1 2021 | $1,345,000 | +345.4% | 42,480 | +553.6% | 0.10% | +187.9% |
| Q4 2020 | $302,000 | -51.0% | 6,499 | -65.3% | 0.03% | -68.9% |
| Q3 2020 | $616,000 | +13.2% | 18,711 | -5.6% | 0.11% | +68.3% |
| Q2 2020 | $544,000 | +153.0% | 19,831 | +67.9% | 0.06% | +270.6% |
| Q3 2019 | $215,000 | +117.2% | 11,814 | +13.8% | 0.02% | +183.3% |
| Q1 2019 | $99,000 | -85.5% | 10,385 | -82.9% | 0.01% | -85.7% |
| Q3 2018 | $684,000 | +273.8% | 60,812 | +166.0% | 0.04% | +320.0% |
| Q4 2017 | $183,000 | – | 22,861 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |